Dub Biologics
We are an early stage company developing a therapeutic to address fibrotic diseases. Our novel self-delivering siRNA has demonstrated preclinical efficacy in corneal scarring-a model tissue for the study of fibrosis. With over 1.5 million global citizens affected by corneal blindness, our goal is to provide a sustainable equitable solution. Our current work includes expansion into other disease indications. We have generated preliminary data demonstrating our therapeutic has efficacy in acute dermal wounds. For additional details, partnership or investment opportunities, please contact us!
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Dub Biologics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Dub Biologics
1 distinct titles indexed · top 1 shown.
- 1drug design consultant
Sign up to unlock all 1 contacts at Dub Biologics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Dub Biologics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.